Axogen Historical Balance Sheet

AXGN Stock

USD 12.47 0.07 0.56%

Trend analysis of Axogen Inc balance sheet accounts such as Short Long Term Debt Total of 72.8 M, Other Current Liabilities of 18 M or Total Current Liabilities of 32 M provides information on Axogen's total assets, liabilities, and equity, which is the actual value of Axogen Inc to its prevalent stockholders. By breaking down trends over time using Axogen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Axogen Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Axogen Inc is a good buy for the upcoming year.

Axogen Inventory

24.17 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

About Axogen Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Axogen Inc at a specified time, usually calculated after every quarter, six months, or one year. Axogen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Axogen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Axogen currently owns. An asset can also be divided into two categories, current and non-current.

Axogen Balance Sheet Chart

At this time, Axogen's Net Debt is very stable compared to the past year. As of the 15th of November 2024, Cash is likely to grow to about 38.9 M, though Retained Earnings are likely to grow to (267.2 M).

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Axogen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Axogen Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Axogen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Axogen Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Axogen's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Axogen Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	67.5M	67.4M	69.3M	72.8M
Total Assets	208.0M	195.4M	196.8M	206.7M

Short Long Term Debt Total Total Assets

Axogen balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Other Current Assets	Accounts Payable	Common Stock Total Equity	Common Stock
Total Assets		0.64	0.98	0.94	0.93	0.86	0.4	-0.94	0.68	0.85	-0.69	0.69	0.96	0.89	0.71	0.94	0.99	0.82	0.84	0.9	-0.37	0.85	0.88	0.84	0.89	0.88
Short Long Term Debt Total	0.64		0.7	0.69	0.33	0.84	0.83	-0.78	0.49	0.84	-0.76	0.05	0.67	0.63	0.97	0.71	0.64	0.94	0.84	0.32	0.08	0.8	0.82	0.63	0.66	0.62
Other Current Liab	0.98	0.7		0.97	0.86	0.9	0.46	-0.94	0.71	0.9	-0.72	0.58	0.96	0.86	0.77	0.95	0.96	0.87	0.9	0.82	-0.35	0.89	0.93	0.86	0.87	0.85
Total Current Liabilities	0.94	0.69	0.97		0.82	0.9	0.44	-0.96	0.74	0.89	-0.75	0.5	0.98	0.91	0.75	0.97	0.96	0.87	0.89	0.77	-0.35	0.91	0.87	0.94	0.92	0.9
Total Stockholder Equity	0.93	0.33	0.86	0.82		0.63	0.08	-0.78	0.62	0.63	-0.47	0.86	0.85	0.82	0.4	0.8	0.91	0.55	0.62	0.97	-0.42	0.64	0.68	0.72	0.8	0.81
Property Plant And Equipment Net	0.86	0.84	0.9	0.9	0.63		0.76	-0.9	0.47	1.0	-0.9	0.22	0.89	0.72	0.91	0.93	0.85	0.96	1.0	0.54	-0.29	0.98	0.92	0.87	0.75	0.7
Net Debt	0.4	0.83	0.46	0.44	0.08	0.76		-0.53	-0.02	0.76	-0.79	-0.25	0.42	0.27	0.87	0.52	0.38	0.79	0.75	0.01	0.0	0.69	0.65	0.44	0.3	0.25
Retained Earnings	-0.94	-0.78	-0.94	-0.96	-0.78	-0.9	-0.53		-0.69	-0.9	0.79	-0.49	-0.97	-0.93	-0.81	-0.97	-0.97	-0.9	-0.9	-0.76	0.2	-0.92	-0.86	-0.92	-0.95	-0.92
Cash	0.68	0.49	0.71	0.74	0.62	0.47	-0.02	-0.69		0.46	-0.22	0.59	0.69	0.81	0.47	0.63	0.7	0.57	0.47	0.7	-0.16	0.51	0.61	0.59	0.81	0.81
Non Current Assets Total	0.85	0.84	0.9	0.89	0.63	1.0	0.76	-0.9	0.46		-0.9	0.21	0.88	0.71	0.91	0.93	0.84	0.95	1.0	0.53	-0.29	0.98	0.92	0.87	0.74	0.69
Non Currrent Assets Other	-0.69	-0.76	-0.72	-0.75	-0.47	-0.9	-0.79	0.79	-0.22	-0.9		-0.05	-0.75	-0.59	-0.81	-0.83	-0.71	-0.84	-0.9	-0.35	0.23	-0.9	-0.7	-0.81	-0.62	-0.57
Cash And Short Term Investments	0.69	0.05	0.58	0.5	0.86	0.22	-0.25	-0.49	0.59	0.21	-0.05		0.54	0.65	0.09	0.45	0.66	0.22	0.2	0.93	-0.28	0.21	0.4	0.32	0.59	0.66
Net Receivables	0.96	0.67	0.96	0.98	0.85	0.89	0.42	-0.97	0.69	0.88	-0.75	0.54		0.93	0.72	0.98	0.98	0.84	0.88	0.8	-0.32	0.91	0.84	0.94	0.94	0.91
Common Stock Shares Outstanding	0.89	0.63	0.86	0.91	0.82	0.72	0.27	-0.93	0.81	0.71	-0.59	0.65	0.93		0.64	0.88	0.94	0.75	0.71	0.85	-0.13	0.75	0.72	0.83	0.99	0.99
Non Current Liabilities Total	0.71	0.97	0.77	0.75	0.4	0.91	0.87	-0.81	0.47	0.91	-0.81	0.09	0.72	0.64		0.77	0.69	0.98	0.91	0.38	-0.08	0.86	0.89	0.68	0.66	0.62
Inventory	0.94	0.71	0.95	0.97	0.8	0.93	0.52	-0.97	0.63	0.93	-0.83	0.45	0.98	0.88	0.77		0.96	0.87	0.93	0.73	-0.32	0.96	0.84	0.96	0.9	0.86
Other Stockholder Equity	0.99	0.64	0.96	0.96	0.91	0.85	0.38	-0.97	0.7	0.84	-0.71	0.66	0.98	0.94	0.69	0.96		0.81	0.84	0.88	-0.31	0.87	0.84	0.9	0.94	0.93
Total Liab	0.82	0.94	0.87	0.87	0.55	0.96	0.79	-0.9	0.57	0.95	-0.84	0.22	0.84	0.75	0.98	0.87	0.81		0.95	0.52	-0.17	0.92	0.93	0.79	0.78	0.74
Property Plant And Equipment Gross	0.84	0.84	0.9	0.89	0.62	1.0	0.75	-0.9	0.47	1.0	-0.9	0.2	0.88	0.71	0.91	0.93	0.84	0.95		0.52	-0.29	0.98	0.91	0.88	0.75	0.69
Total Current Assets	0.9	0.32	0.82	0.77	0.97	0.54	0.01	-0.76	0.7	0.53	-0.35	0.93	0.8	0.85	0.38	0.73	0.88	0.52	0.52		-0.34	0.54	0.64	0.63	0.81	0.84
Short Term Debt	-0.37	0.08	-0.35	-0.35	-0.42	-0.29	0.0	0.2	-0.16	-0.29	0.23	-0.28	-0.32	-0.13	-0.08	-0.32	-0.31	-0.17	-0.29	-0.34		-0.29	-0.3	-0.31	-0.12	-0.11
Intangible Assets	0.85	0.8	0.89	0.91	0.64	0.98	0.69	-0.92	0.51	0.98	-0.9	0.21	0.91	0.75	0.86	0.96	0.87	0.92	0.98	0.54	-0.29		0.87	0.93	0.8	0.74
Other Current Assets	0.88	0.82	0.93	0.87	0.68	0.92	0.65	-0.86	0.61	0.92	-0.7	0.4	0.84	0.72	0.89	0.84	0.84	0.93	0.91	0.64	-0.3	0.87		0.74	0.74	0.71
Accounts Payable	0.84	0.63	0.86	0.94	0.72	0.87	0.44	-0.92	0.59	0.87	-0.81	0.32	0.94	0.83	0.68	0.96	0.9	0.79	0.88	0.63	-0.31	0.93	0.74		0.87	0.82
Common Stock Total Equity	0.89	0.66	0.87	0.92	0.8	0.75	0.3	-0.95	0.81	0.74	-0.62	0.59	0.94	0.99	0.66	0.9	0.94	0.78	0.75	0.81	-0.12	0.8	0.74	0.87		0.99
Common Stock	0.88	0.62	0.85	0.9	0.81	0.7	0.25	-0.92	0.81	0.69	-0.57	0.66	0.91	0.99	0.62	0.86	0.93	0.74	0.69	0.84	-0.11	0.74	0.71	0.82	0.99

Click cells to compare fundamentals

Axogen Account Relationship Matchups

Axogen balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	154.6M	201.4M	208.0M	195.4M	196.8M	206.7M
Short Long Term Debt Total	3.3M	53.8M	67.5M	67.4M	69.3M	72.8M
Other Current Liab	10.9M	16.5M	16.5M	13.5M	17.1M	18.0M
Total Current Liabilities	20.9M	22.8M	24.3M	23.8M	30.4M	32.0M
Total Stockholder Equity	132.2M	123.1M	112.6M	101.0M	95.7M	100.4M
Property Plant And Equipment Net	18.1M	54.1M	78.1M	93.7M	104.3M	109.5M
Net Debt	(32.4M)	5.0M	34.7M	52.1M	32.3M	33.9M
Retained Earnings	(179.9M)	(203.6M)	(230.6M)	(259.6M)	(281.3M)	(267.2M)
Cash	35.7M	48.8M	32.8M	15.3M	37.0M	38.9M
Non Current Assets Total	19.6M	56.1M	81.0M	97.3M	108.8M	114.3M
Non Currrent Assets Other	(19.6M)	15.7M	(81.0M)	(97.3M)	(87.6M)	(83.2M)
Cash And Short Term Investments	96.5M	104.0M	84.1M	48.8M	37.0M	20.0M
Net Receivables	16.9M	17.6M	18.2M	22.2M	25.1M	26.4M
Common Stock Shares Outstanding	39.2M	40.0M	41.2M	42.1M	42.9M	45.0M
Liabilities And Stockholders Equity	154.6M	201.4M	208.0M	195.4M	196.8M	206.7M
Non Current Liabilities Total	1.6M	55.4M	71.2M	70.6M	70.7M	74.3M
Inventory	13.9M	12.5M	16.7M	18.9M	23.0M	24.2M
Other Stockholder Equity	311.6M	326.4M	342.8M	360.2M	376.5M	395.4M
Total Liab	22.5M	78.2M	95.5M	94.4M	101.2M	106.2M
Property Plant And Equipment Gross	18.1M	54.1M	85.7M	93.7M	118.0M	123.9M
Total Current Assets	135.0M	145.3M	127.0M	98.1M	88.0M	92.4M
Short Term Debt	1.7M	1.7M	1.8M	1.3M	1.5M	1.5M
Intangible Assets	1.5M	2.1M	2.9M	3.6M	4.5M	4.8M
Other Current Assets	1.7M	11.1M	8.1M	8.2M	8.8M	9.3M
Accounts Payable	8.3M	4.6M	5.9M	9.0M	11.8M	12.4M
Common Stock Total Equity	396K	406K	417K	424K	487.6K	512.0K
Common Stock	396K	406K	417K	424K	431K	452.6K
Other Liab	164K	112K	15K	3K	2.7K	2.6K
Property Plant Equipment	18.1M	38.4M	78.1M	93.7M	107.7M	113.1M
Net Tangible Assets	130.6M	121.1M	109.7M	97.4M	112.0M	58.6M
Long Term Debt	1.6M	52.9M	65.6M	66.1M	46.6M	33.6M
Long Term Debt Total	30K	52.9M	65.6M	66.1M	76.0M	79.8M
Capital Surpluse	311.6M	326.4M	342.8M	360.2M	414.2M	210.4M
Short Long Term Debt	4.7M	28K	1.7M	863K	776.7K	737.9K

Pair Trading with Axogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Axogen Stock

0.52	GH	Guardant Health	Pair Corr
0.49	DXCM	DexCom Inc	Pair Corr
0.41	SNDA	Sonida Senior Living	Pair Corr
0.39	AGL	agilon health	Pair Corr
0.37	MBOT	Microbot Medical	Pair Corr

The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.

The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:

How To Invest In Axogen

Details

Is Axogen Stock a good investment?

Details

What is Axogen's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.33)

Revenue Per Share

4.16

Quarterly Revenue Growth

0.179

Return On Assets

(0.03)

Return On Equity

(0.15)

The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Axogen Historical Balance Sheet

Axogen Inventory

24.17 Million

About Axogen Balance Sheet Analysis

Axogen Balance Sheet Chart

Total Assets

Total Current Liabilities

Axogen balance sheet Correlations

Axogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Axogen balance sheet Accounts

Pair Trading with Axogen

Moving against Axogen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Non Current Assets Total
Other Stockholder Equity	+ 0.99	Total Assets
Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.97	Retained Earnings
Inventory	- 0.97	Retained Earnings
Net Receivables	- 0.97	Retained Earnings
Retained Earnings	- 0.96	Total Current Liabilities
Common Stock Total Equity	- 0.95	Retained Earnings
Retained Earnings	- 0.94	Other Current Liab